Upal Basu Roy, PhD, MPH, discusses the challenges of interpreting molecular testing results in lung cancer.
Upal Basu Roy, PhD, MPH
Advertisement
Articles by Upal Basu Roy, PhD, MPH
Upal Basu Roy, PhD, MPH, discusses addressing barriers to biomarker testing in lung cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
2
NCCN Guidelines Recognize MammaPrint/BluePrint for Determining Anthracycline Benefit in Breast Cancer
3
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
4
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
5